Systematic Review with Meta-Analysis: Efficacy and Safety of Direct-Acting Antivirals for Chronic Hepatitis C Genotypes 5 and 6

Figure 3

Pooling SAE rates of SOFL/LDV regimen on HCV genotype 6. SAE, serious adverse event; HCV, hepatitis C virus; SOF, sofosbuvir; LDV, ledipasvir.